Lucy Yan, MD, PhD (he/him/his)

VP, Clinical Development
Rigel Pharmaceuticals

Disclosure(s): Rigel Pharmaceuticals: Employee, Stocks/Bonds

Lucy Yan, MD, PhD
Lucy is at VP of Clinical Development at Rigel Pharmaceuticals, Inc. Prior to joining Rigel, she served as Senior Medical Director at Adverum Biotechnologies, Inc. Before her work at Adverum, Lucy served for 17 years in capacities of increasing importance in Clinical Development at Amgen and Pfizer.

Poster(s):

• 1141 - Phase 3 Trial (in progress) of the SYK inhibitor Fostamatinib in Patients Hospitalized with COVID-19: Protocol and Study Implementation Updates
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET